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CC BY-NC-ND license (http://creativeBackground: Serum lactate was used to predict the severity and outcome of neonatal hypoxic
ischemic encephalopathy (HIE) before the era of therapeutic hypothermia (TH). There is no
report on neurodevelopment (ND) outcome of neonates with HIE treated with TH in Taiwan.
Methods: Between April 2011 and December 2012, newborn infants admitted to Chang Gung
Memorial Hospital (CGMH), with gestational age > 35 weeks and birth weight  1800 g, who
had acute perinatal events, evidence of significant fetal compromise, and ongoing clinical en-
cephalopathy were prospectively enrolled for TH. Whole body cooling method was used to
maintain the affected neonate’s esophageal temperature at 33.5  0.5C for 72 hours. Demo-
graphic data were recorded and hemogram, biochemical parameters, serum lactate, and cre-
atine kinase (CK) were measured as well. Brain magnetic resonance imaging (MRI) was
performed between 7 and 14 days of life. ND outcome of infants was evaluated by Bayley
Scales of Infant Development, third edition (BSID-III) at 24 months of corrected age. Poor ND
(PND) outcome was defined as infants surviving with either disability or ND delay.
Results: Seventeen patients were enrolled. Fifty-nine percent of babies (10/17) were born
through cesarean section and 77% of babies (13/17) were transferred from outside hospitals.
Six babies were moderate HIE and 11 babies were severe HIE. Among the 14 surviving patients,eonatology, Department of Pediatrics, Chang Gung Memorial Hospital, 5e7, Fu-Shin Street, Guishan
.com (M.-C. Chiang).
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36 M.-C. Chiang et aleight infants had PND outcome. There was no difference in demographic data between infants
with and without PND. Serum level of lactate (mg/dL) after 72 hours of TH was higher (35.6 vs.
13.8, p Z 0.042) in infants with PND. Neonates with abnormal brain MRI findings were also
associated with PND (p Z 0.01).
Conclusion: This is the first report on ND outcome of neonates with HIE treated with TH in
Taiwan. Higher serum level of lactate following TH and abnormal results of brain MRI are asso-
ciated with poor ND outcome.
Copyright ª 2016, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Perinatal asphyxia and neonatal hypoxic ischemic enceph-
alopathy (HIE) are associated with high morbidity and
mortality rates worldwide.1,2 Current evidence and guide-
lines recommend that newly born infants born at or near
term with evolving moderate to severe HIE should be
offered therapeutic hypothermia (TH).3e6 Used clinically,
TH improves both survival and the neurologic outcomes of
those who survive, but the effect is only modest.7e10
Adjuvant therapies combined with TH are emerging and
may improve the outcome of neonates with HIE.11e13
Hence, it is important to study biomarkers of neonatal
HIE which can be used to monitor severity of illness or
therapeutic effects when discovering new therapies.
TH for neonatal HIE was introduced into Taiwan in 2010
and only 35.5% of moderate to severe HIE patients received
TH between January 2010 and November 2011 in Taiwan.14
To date, there are no neurodevelopment (ND) outcome
data of neonates with HIE treated with TH in Taiwan. The
aim of the study was to describe our experiences of TH in
managing neonates with HIE and to report the ND outcome
of affected infants. In addition, we collected and analyzed
parameters and biochemical markers to discover factors
associated with the ND outcome.
2. Materials and methods
This prospective study was approved by the Institutional
Review Board of Chang Gung Memorial Hospital (CGMH) and
was conducted in the neonatal intensive care unit (NICU) at
CGMH during the period between April 2011 and December
2012. CGMH is a medical center in the northern part of
Taiwan which has approximately 3000e4000 deliveries
annually and a level III NICU with 37 intensive care beds as
well as 70 intermediate beds. CGMH has an active neonatal
transport team and one sixth of the NICU admissions
were through neonatal transport. Most of the outside hos-
pitals are located within 30e60 minutes’ drive from our
hospital.
Newborn infants with gestational age > 35 weeks and
birth weight  1800g, who were affected with moderate to
severe HIE,15 and met the criteria for TH were enrolled.
Eligibility criteria were in accordance with the National
Institute of Child Health and Human Development trial7with modification (Figure 1 and Table 1). In brief,
affected infants should have acute perinatal events, evi-
dence of significant fetal compromise, and ongoing clinical
encephalopathy. The exclusion criteria in this study include
major congenital anomaly, intracranial hemorrhage, avail-
ability of 1st hour blood gas with pH > 7.15 and base deficit
<10, and refusal of therapy by family.
Once the infant fulfilled the criteria, TH would be
commenced within 6 hours of life. Affected newborn in-
fants were cooled by Blanketrol II (Hyper-Hypothermia
System, Cincinnati Sub-Zero, Cincinnati, OH) to maintain
their esophageal temperature at 33e34C for 72 hours.7
Patients would be sedated if they were shivering or
became irritable. The patients then were rewarmed slowly
(< 0.5C/h) to 36.5C. During the hypothermic period, vital
signs were recorded every 30 minutes in the first 4 hours,
every 60 minutes in 4e12 hours, and every 2 hours in the
12e72 hours. Hemograms, electrolytes, blood sugar, blood
gas analysis, creatine kinase (CK), lactate, as well as liver
and renal functions, were measured regularly.
Amplitude integrated electroencephalography was used
to monitor seizures. Antiepileptic drugs would be pre-
scribed if there was either a clinical or electrographic
seizure. Brain ultrasonography was performed before TH to
exclude intracranial hemorrhage and congenital anomalies,
and brain magnetic resonance imaging (MRI) was performed
between 7 and 14 days of age. Abnormal MRI findings were
defined as the presence of abnormal signals of the posterior
limb of the internal capsule, the basal ganglia, thalami, or
watershed areas.
Bayley Scales of Infant Development, third edition (BSID-
III) were used to assess ND outcome of surviving infants.
Neurodevelopmental delay was defined as presence of any
one of the following domains: cognitive scores < 85, lan-
guage scores < 79, and motor scores < 85 at 24 months of
corrected age. In this study, PND outcome was defined as
surviving infants with one or more of the following:
disability (cerebral palsy, bilateral blindness, or bilateral
hearing loss) or delay (no disability but with lower BSID-III
scores, defined as previous description).
Statistical analysis was performed with SPSS Statistics
version 20 (IBM, Armonk, NY). Continuous variables were
analyzed by Mann-Whitney U test and categorical variables
were analyzed by Fisher’s exact test. Data were presented
as median (range). A p value < 0.05 indicated statistical
significance.
Figure 1 Eligibility criteria for therapeutic hypothermia in neonates with hypoxic ischemic encephalopathy (HIE) at Chang Gung
Memorial Hospital (CGMH). ABG Z arterial blood gas.
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Seventeen patients were enrolled in the study, 10 of whom
were baby boys. Fifty-nine percent of babies (10/17) were
born through cesarean section and 77% of babies (13/17)
were transferred from outside hospitals. Six babies were
moderate HIE (35%) and 11 babies were severe HIE (65%).
The most common intrapartum complications associated
with the development of HIE were fetal heart beat decel-
eration, followed by placenta abruption and tight nuchal
cord.
During the study period, the age to start TH among
affected neonates was 5 (2.9, 7.0) hours old. Seventy-seven
percent of patients were transferred from outside hospitals
and their age at admission was 148 (106, 324) minutes old.The age (minutes old) to start TH among inborn infants was
211 (173, 247) and was 309 (210, 421) among outborn in-
fants (p Z 0.023). The rewarm time for the cooling babies
was 6.5 (6, 14) hours.
Three babies were moribund and were diagnosed as se-
vere HIE. Apgar scores at 1 minute and 5 minute of them
were 0 (0, 1) and 1 (0, 1), respectively. The pH level of first
blood gas analysis was 6.5 (6.35, 6.53). Cardiopulmonary
resuscitation (CPR) was performed for these three patients
immediately after birth and the duration of CPR was 51 (12,
60) minutes. At the request of the family, two were still
transferred to our hospital. All 17 patients completed 72
hours of TH without premature termination of TH. No
mortality related to the TH occurred during the study
period. Eighty-eight percent (15/17) of patients developed
Table 1 Diagnostic criteria for moderate or severe encephalopathy.
Category Moderate encephalopathy Severe encephalopathy
Level of consciousness Lethargy Stupor or coma
Spontaneous activity Decreased activity No activity
Posture Distal flexion, complete extension Decerebrate
Tone Hypotonia (focal or general) Flaccid
Primitive reflexes Weak suck or incomplete Moro reflex Absent suck or Moro reflex
Autonomic system Constricted pupils, bradycardia, or
periodic/irregular breathing
Deviated/ dilated/ nonreactive pupils,
variable heart rate, or apnea
Table 2 Demographic data and neurodevelopmental outcome.
Without PND (n Z 4) PND (n Z 8) p
Gestational age (wk) 39.5  0.6 37.9  1.5 0.061
Birth weight (g) 2658  465 3525  828 0.084
Male/female (n) 4/0 4/4 0.208
Vaginal delivery/cesarean section (n) 0/4 3/5 0.491
Apgar score at 1 min 2  1 2  2 0.746
Apgar score at 5 min 4  1 4  3 0.733
Inborn/outborn (n) 1/3 2/6 1.0
PND Z poor neurodevelopment.
38 M.-C. Chiang et alseizure within 24 hours of life. Phenobarbital was used as
the first line antiepileptic drug to treat neonatal seizure.
Palliative therapy was given to all three moribund patients
after TH and family meetings. Treatment was withdrawn
within 10 days of life. Thus, the survival rate was 82% (14/
17). The remaining 14 infants were discharged and followed
in the outpatient department. Two infants lost follow-up.
Both were baby boys, without CPR after birth, whose Apgar
scores were 1 and 4 at 1 and 5 minutes, respectively, and
who were diagnosed as moderate HIE. They received ND
evaluation by BSID-III at 6 months of age and the scores
were normal without any delay. Finally, 86% of surviving
patients were followed to 24 months of age, and they were
analyzed to study factors associated with ND outcome.
Eight infants had PND outcome in the study; 87.5% of
them were severe HIE and 12.5% were moderate HIE. The
demographic information, clinical features, and laboratory
data of the infants with PND and without PND are depicted
in Tables 2 and 3. Affected neonates with abnormal brain
MRI findings were associated with the development of PND
at 24 months of age (Table 3). Serum levels of lactate and
CK were routinely measured in affected neonates before
and after TH. In the study, we showed that serum level of
lactate (mg/dL) after 72 hours of TH was higher (35.6 vs.
13.8, pZ 0.042) in infants with PND comparing with infants
without PND at 24 months of age (Table 3). The serum level
of lactate after 72 hours of TH was 103.4 mg/dL for the
patient who was affected with moderate HIE and had PND.
By contrast, the serum level of lactate after 72 hours of TH
was 11.5 mg/dL for the patient who was affected by severe
HIE but was without PND at 24 months of age.4. Discussion
Before the era of TH, newborn infants with moderate en-
cephalopathy had a 20e35% risk of later sequelae from theinsult, although those whose neurologic examinations were
completely normal within 1 week had a good likelihood of
normal outcome.16 Infants with severe encephalopathy had
a 75% risk of dying in the neonatal period, and among sur-
vivors, an almost universal risk of sequelae existed.16e18
The results of the National Institute of Child Health and
Human Development (NICHD) trial indicated that whole-
body hypothermia reduced the risk of death or disability
in infants with moderate or severe HIE.7 By contrast, the
results of the Total Body Hypothermia for Neonatal En-
cephalopathy (TOBY) trial showed that TH did not signifi-
cantly reduce the combined rate of death or severe
disability in infants with moderate or severe HIE, but
resulted in improved neurologic outcomes in survivors.9 In
the current small study, 16.7% of infants with moderate HIE
had PND outcome. Among infants with severe HIE, 27.3%
died and 87.5% of survivors had PND outcome. Ours is the
first study to report ND follow-up data in infants with
moderate to severe HIE receiving TH in Taiwan, and our
results further support the current evidence7,9,16e18 of
beneficial effects of TH in treating neonatal HIE.
The duration of the latent phase or therapeutic window
between primary and secondary energy failure secondary
to hypoxic ischemic brain injury was noted to be approxi-
mately 6 hours in near term fetal sheep treated with hy-
pothermia initiated at varying intervals following timed
hypoxic ischemic injury.12,19e21 In our study, the average
age to start TH among affected neonates was 4.8 hours old.
Not surprisingly, the time to start TH among inborn infants
was earlier than that among outborn infants, but there was
no difference in terms of ND outcome. If we used cutoff
time of starting TH to < 3.5 or < 4 hours of age, there was
also no difference (data not shown). In the TOBY trial, the
relative risk for the primary outcome with cooling which
was started < 4 hours after birth was 0.77 [95% confidence
interval (CI), 0.44e1.04], whereas when cooling started
between 4 and 6 hours after birth, the relative risk was 0.95
Table 3 Clinical features, laboratory data and neurodevelopmental outcome.
Without PND (n Z 4) PND (n Z 8) p
HIE 0.067
moderate (n) 3 1
severe (n) 1 7
Seizure (n) 0.333
Yes/no 3/1 8/0
Brain MRI findings (n) 0.01*
Normal/abnormal 4/0 1/7
1st blood gas pH value 6.97 (6.73, 7.32) 7.02 (6.72, 7.43) 0.850
Lactate (0 h) (mg/dL) 162.5 (72.7, 191.8) 139.5 (32.2, 313.7) 0.734
Lactate (72 h) (mg/dL) 13.8 (11.5, 22.1) 35.6 (13.7, 103.4) 0.042*
D Lactate (%) 92.3 (69.6, 92.7) 70.0 (14.4, 87.5) 0.042*
CK (0 h) (IU/L) 2090 (712, 15323) 1630 (470, 8822) 0.705
CK (72 h) (IU/L) 1276 (446, 1969) 755 (73, 2318) 0.522
D CK (%) 51.6 (8.8, 87.2) 69.5 (19.1, 84.5) 0.522
Serum lactate and CK were measured before and after therapeutic hypothermia.
Continuous variables were presented as median (range) and analyzed by Mann-Whitney U test.
CK Z creatine kinase; HIE Z hypoxic ischemic encephalopathy; MRI Z magnetic resonance imaging; PND Z poor neurodevelopment.
*p < 0.05. D Lactate：Lactate (0 hour) e Lactate (72 hours)/Lactate (0 hour). D CK：CK (0 hour) e CK (72 hours)/CK (0 hour).
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should be initiated before 6 hours of age, and as early as
possible.5,9
Serum or plasma levels of lactate were used to predict
severity and outcome of neonatal HIE before the era of
TH.22e26 It has been demonstrated that a plasma lactate
concentration > 7.5 mmol/L (67.5 mg/dL) taken within 1
hour of life was associated with moderate or severe HIE
with a sensitivity of 94% and specificity of 67%.24 In a
retrospective study of the Japanese National Center for
Child Health and Development, serum levels of lactate and
CK at admission were significantly higher in infants with
poor outcome compared to those with favorable outcomes.
The average levels of lactate and CK in the poor outcome
group were 11.9 mmol/L (107.1 mg/dL) and 1022 IU/L.26
Shah et al24 also indicated that the highest recorded
lactate level in the 1st hour of life and serial measurements
of lactate were important predictors of moderate-to-
severe HIE. We measured serum levels of lactate and CK
within 6 hours of life as well as after TH in affected infants.
Both the levels of lactate and CK of our patients were
higher than those of the Japanese studies26 indicating more
severe illness, but the outcome was better than in the
historical data.16e18 We were unable to compare our data
with that of Shah’s study24 equally, because nearly 80% of
our patients were transferred from outside hospitals.
Hence, levels of lactate were not all drawn and measured
within the 1st hour of life. In addition, all of our patients
underwent TH.
MRI can delineate the sites and extent of neuronal
injury. Imaging predictors of risk of adverse outcome
include absence of signals from the posterior limb of the
internal capsule, ischemic damage to the basal ganglia,
thalami, and watershed areas.27,28 A nested substudy from
the TOBY trial indicated that MRI could accurately predict
outcome of neonates with HIE at 18 months of age in cooled
and non-cooled infants.29 Similar to the TOBY trial, our
study showed that findings of MRI were associated with
outcome of affected infants at 24 months of age.Finer et al16 indicated that neonates with moderate HIE
whose neurologic examinations were completely normal
within 1 week had a good likelihood of normal outcome
before the era of TH. In a study recruiting 51 neonates with
HIE, the best predictive value for neurological outcome at
24 months of age was seen with neurological examination at
discharge (positive and negative predictive values of 86%
and 72%, respectively).30 In the current study, there were
four patients with moderate HIE, whose neurological ex-
aminations were normal before discharge. As for the eight
patients with severe HIE, the neurological examinations
were abnormal before discharge. There was no significant
difference between infants with normal and abnormal
neurological examinations before discharge in terms of
outcome.
The limitation of the current study is that the sample
size is relatively small. In the era of TH, it is important to
address the facts we mentioned as well as to search for and
study biochemical parameters or biomarkers for the sake of
monitoring severity of illness or therapeutic effects when
treating patients or discovering new therapies.
This is the first report on neurodevelopmental outcome
of neonates with HIE receiving TH in Taiwan. Based on our
results, we conclude that in the era of TH, higher serum
levels of lactate following TH and abnormal results of brain
MRI are associated with poor neurodevelopmental outcome
in neonates with HIE.Conflicts of interest
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